In contrast, three of the four Eμ-Myc/RelaT505A tumours showed no significant reduction in lymphoid tumour burden after CCT244747 treatment, while the remaining tumour exhibited only a partial response with a reduction in tumours of the thymus and cervical lymph nodes. The gene discussed is MYC; the disease is neoplasm.